- Home
- ZG vs HOLX Comparison
ZG vs HOLX Comparison
Compare ZG & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZG
- HOLX
- Stock Information
- Founded
- ZG 2004
- HOLX 1985
- Country
- ZG United States
- HOLX United States
- Employees
- ZG N/A
- HOLX N/A
- Industry
- ZG Business Services
- HOLX Medical Electronics
- Sector
- ZG Consumer Discretionary
- HOLX Health Care
- Exchange
- ZG Nasdaq
- HOLX Nasdaq
- Market Cap
- ZG 18.7B
- HOLX 16.3B
- IPO Year
- ZG 2011
- HOLX 1990
- Fundamental
- Price
- ZG $72.04
- HOLX $64.50
- Analyst Decision
- ZG Buy
- HOLX Buy
- Analyst Count
- ZG 25
- HOLX 14
- Target Price
- ZG $82.33
- HOLX $85.42
- AVG Volume (30 Days)
- ZG 696.3K
- HOLX 2.3M
- Earning Date
- ZG 02-11-2025
- HOLX 02-05-2025
- Dividend Yield
- ZG N/A
- HOLX N/A
- EPS Growth
- ZG N/A
- HOLX 50.83
- EPS
- ZG N/A
- HOLX 3.16
- Revenue
- ZG $2,236,000,000.00
- HOLX $4,039,000,000.00
- Revenue This Year
- ZG $16.19
- HOLX $5.33
- Revenue Next Year
- ZG $14.74
- HOLX $5.72
- P/E Ratio
- ZG N/A
- HOLX $20.44
- Revenue Growth
- ZG 14.96
- HOLX 1.76
- 52 Week Low
- ZG $38.06
- HOLX $62.70
- 52 Week High
- ZG $86.58
- HOLX $84.67
- Technical
- Relative Strength Index (RSI)
- ZG 37.39
- HOLX 34.25
- Support Level
- ZG $68.18
- HOLX $62.70
- Resistance Level
- ZG $79.05
- HOLX $65.18
- Average True Range (ATR)
- ZG 2.90
- HOLX 1.55
- MACD
- ZG -1.15
- HOLX -0.18
- Stochastic Oscillator
- ZG 20.98
- HOLX 17.36
About ZG Zillow Group Inc.
Zillow Group Inc is an Internet-based real estate company that offers its customers an on-demand experience for selling, buying, renting, or financing with transparency and ease The group works with real estate agents, brokers, builders, property managers, and landlords to pair technology with top-notch service. The group has brands such as Zillow, Trulia, StreetEasy, Hotpads, Zillow Rentals, Zillow Premier Agent and others.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.